|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Tuesday, April 11, 2017Sedatives May Raise Pneumonia Risk in Alzheimer's
Image
Source: NBNNEWS
Alzheimer's
patients given sedatives such as Valium or Xanax may have an
increased risk for pneumonia, a new study warns.
People
with Alzheimer's disease are often given these drugs, called
benzodiazepines, over the long term, the researchers said.
Examples
of benzodiazepines include alprazolam (Xanax), clonazepam (Klonopin),
diazepam (Valium), and lorazepam (Ativan).
"An
increased risk of pneumonia is an important finding to consider in
treatment of patients with Alzheimer disease. Pneumonia often leads
to admission to hospital, and patients with dementia are at increased
risk of death related to pneumonia," Dr. Heidi Taipale, of
Kuopio Research Center of Geriatric Care at the University of Eastern
Finland, and co-authors wrote.
For
the study, the researchers reviewed data from nearly 50,000
Alzheimer's patients in Finland. The patients' average age was 80 and
about two-thirds were women.
The
study found that people with Alzheimer's who took benzodiazepines
were 30 percent more likely to develop pneumonia than those who
weren't given the sedatives.
The
risk of pneumonia was highest in the first 30 days after starting the
drugs, the findings showed.
The
researchers said their findings are consistent with previous studies.
Because
benzodiazepines are sedating, it's possible that people taking them
may breathe saliva or food into the lungs, increasing the risk of
pneumonia, the study authors suggested.
Taipale's
team said the benefits and risks of these drugs -- including
pneumonia -- need to be carefully considered before giving them to
someone with Alzheimer's disease.
The
study was published April 10 in the CMAJ (Canadian Medical
Association Journal).
The
study is "a good reminder to clinicians to 'first do no harm'
when prescribing these drugs for frail older women and men with
dementia," Dr. Paula Rochon and her co-authors wrote in an
accompanying editorial in the journal. Rochon is from Women's College
Hospital and the University of Toronto.
Story
Source: The
above story is based on materials provided by WEBMD
Note:
Materials may be edited for content and length
|